1. Home
  2. XOMA

as of 11-28-2025 12:52pm EST

$32.23
$0.06
-0.20%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Chart Type:
Time Range:
Founded: 1981 Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: 457.6M IPO Year: N/A
Target Price: $69.50 AVG Volume (30 days): 53.6K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.82 EPS Growth: N/A
52 Week Low/High: $18.35 - $39.92 Next Earning Date: 11-12-2025
Revenue: $47,106,000 Revenue Growth: 118.02%
Revenue Growth (this year): 88.91% Revenue Growth (next year): 13.80%

AI-Powered XOMA Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 75.35%
75.35%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest XOMA Corporation News

XOMA Breaking Stock News: Dive into XOMA Ticker-Specific Updates for Smart Investing

All XOMA News

Share on Social Networks: